secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xylem Inc. (XYL)
CIK:        0001524472
Form:       8-K
Filed at:   2023-01-23T23:59:59+00:00
Accession:  0001193125-23-012563
Event type: m_and_a
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xylem to acquire Evoqua in $7.5B all-stock deal; 0.48 exchange ratio, ~29% premium
--------------------------------------------------------------------------------

- Enterprise value ~$7.5B; Evoqua shareholders receive 0.48 Xylem shares per share, valued at ~$52.89, a 29% premium.
- Combined revenue over $7B in trailing 12 months; expected run-rate cost synergies of $140M within three years.
- Evoqua shareholders will own ~25% of combined company; Xylem shareholders ~75%.
- Transaction expected to close mid-2023, subject to shareholder and regulatory approvals and customary conditions.
- President and CEO Patrick Decker to lead combined company; two Evoqua board members to join Xylem board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1524472/000119312523012563/0001193125-23-012563-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1524472/000119312523012563/d441004d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-012563

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer